YXS inhibits the abnormally high expression of GATA4 in cardiovascular hypertrophy, which can be regulated by interactions between HDAC1 and the general control nonrepressed 5 protein (GCN5). The gene discussed is GATA4; the disease is cardiac hypertrophy.